Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Mesulam, E. Mufson, A. Levey, B. Wainer (1983)
Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkeyJournal of Comparative Neurology, 214
S. Counts, M. Alldred, Shaoli Che, S. Ginsberg, E. Mufson (2014)
Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairmentNeuropharmacology, 79
Jisook Moon, May Chen, S. Gandhy, M. Strawderman, D. Levitsky, K. Maclean, B. Strupp (2010)
Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome.Behavioral neuroscience, 124 3
Li Zhu, Minghao Zhong, Jiaying Zhao, Hannah Rhee, Ina Caesar, E. Knight, L. Volpicelli-Daley, Victor Bustos, William Netzer, Lijuan Liu, Louise Lucast, M. Ehrlich, N. Robakis, S. Gandy, Dongming Cai (2013)
Reduction of Synaptojanin 1 Accelerates Aβ Clearance and Attenuates Cognitive Deterioration in an Alzheimer Mouse Model*The Journal of Biological Chemistry, 288
S. Zeisel (2011)
Choline: Clinical Nutrigenetic/Nutrigenomic Approaches for Identification of Functions and Dietary RequirementsLifestyle Genomics, 3
B. Efron (2007)
Correlation and Large-Scale Simultaneous Significance TestingJournal of the American Statistical Association, 102
Hui Wang, Andrea Megill, P. Wong, A. Kirkwood, Hey-Kyoung Lee (2014)
Postsynaptic Target Specific Synaptic Dysfunctions in the CA3 Area of BACE1 Knockout MicePLoS ONE, 9
Yueh-Sheng Chen, Shang-Der Chen, Chia-Lin Wu, Shiang-Suo Huang, Ding-I Yang (2014)
Induction of sestrin2 as an endogenous protective mechanism against amyloid beta-peptide neurotoxicity in primary cortical cultureExperimental Neurology, 253
I. Ferrer, M. Barrachina, B. Puig, M. Lagrán, E. Martí, J. Ávila, M. Dierssen (2005)
Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic modelsNeurobiology of Disease, 20
M. Rachidi, C. Lopes (2010)
Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome.American journal on intellectual and developmental disabilities, 115 2
J. Miners, Z. Helmond, P. Kehoe, S. Love (2010)
Changes with Age in the Activities of β‐Secretase and the Aβ‐Degrading Enzymes Neprilysin, Insulin‐Degrading Enzyme and Angiotensin‐Converting EnzymeBrain Pathology, 20
R. Reeves, N. Irving, T. Moran, A. Wohn, C. Kitt, S. Sisodia, C. Schmidt, R. Bronson, M. Davisson (1995)
A mouse model for Down syndrome exhibits learning and behaviour deficitsNature Genetics, 11
D. Hartley, T. Blumenthal, M. Carrillo, G. DiPaolo, Lucille Esralew, K. Gardiner, A. Granholm, K. Iqbal, M. Krams, C. Lemere, I. Lott, W. Mobley, S. Ness, R. Nixon, H. Potter, R. Reeves, M. Sabbagh, W. Silverman, B. Tycko, M. Whitten, T. Wisniewski (2015)
Down syndrome and Alzheimer's disease: Common pathways, common goalsAlzheimer's & Dementia, 11
Suqing Wang, Rui Wang, Lang Chen, David Bennett, D. Dickson, Deng-shun Wang (2010)
Expression and functional profiling of neprilysin, insulin‐degrading enzyme, and endothelin‐converting enzyme in prospectively studied elderly and Alzheimer’s brainJournal of Neurochemistry, 115
G. Lindblom, G. Orädd (2009)
Lipid lateral diffusion and membrane heterogeneity.Biochimica et biophysica acta, 1788 1
X. Altafaj, Eduardo Martín, J. Ortiz-Abalia, Aitana Valderrama, Cristina Lao-Peregrin, M. Dierssen, C. Fillat (2013)
Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndromeNeurobiology of Disease, 52
its Folate, Other Vitamins (1998)
Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline
Xiangyou Hu, Jinxuan Hu, Lu Dai, B. Trapp, R. Yan (2015)
Axonal and Schwann Cell BACE1 Is Equally Required for Remyelination of Peripheral NervesThe Journal of Neuroscience, 35
J. Wegiel, C. Gong, Y. Hwang (2011)
The role of DYRK1A in neurodegenerative diseasesThe FEBS Journal, 278
M. Alldred, Sang Lee, E. Petkova, S. Ginsberg (2014)
Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer’s disease (AD)Brain Structure and Function, 220
C. Pedraza, Petar Podlesniy, N. Vidal, J. Arévalo, Ramee Lee, B. Hempstead, I. Ferrer, M. Iglesias, C. Espinet (2005)
Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR.The American journal of pathology, 166 2
K. Wisniewski, A. Dalton, D. McLachlan, G. Wen, H. Wisniewski (1985)
Alzheimer's disease in Down's syndromeNeurology, 35
M. Kurt, D. Davies, M. Kidd, M. Dierssen, J. Flórez (2000)
Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) miceBrain Research, 858
Christy Kelley, B. Powers, R. Velazquez, Jessica Ash, S. Ginsberg, B. Strupp, E. Mufson (2014)
Sex Differences in the Cholinergic Basal Forebrain in the Ts65Dn Mouse Model of Down Syndrome and Alzheimer's DiseaseBrain Pathology, 24
S. Ginsberg, M. Alldred, S. Counts, A. Cataldo, R. Neve, Ying Jiang, J. Wuu, M. Chao, E. Mufson, R. Nixon, Shaoli Che (2010)
Microarray Analysis of Hippocampal CA1 Neurons Implicates Early Endosomal Dysfunction During Alzheimer's Disease ProgressionBiological Psychiatry, 68
P. McGowan, M. Meaney, M. Szyf (2008)
Diet and the epigenetic (re)programming of phenotypic differences in behaviorBrain Research, 1237
Frank Wippich, B. Bodenmiller, M. Trajkovska, Stefanie Wanka, R. Aebersold, L. Pelkmans (2013)
Dual Specificity Kinase DYRK3 Couples Stress Granule Condensation/Dissolution to mTORC1 SignalingCell, 152
L. Gatta, A. Albertini, R. Ravid, D. Finazzi (2002)
Levels of β-secretase BACE and α-secretase ADAM10 mRNAs in Alzheimer hippocampusNeuroreport, 13
J. Cooper, A. Salehi, J. Delcroix, C. Howe, P. Belichenko, Jane Chua-Couzens, J. Kilbridge, E. Carlson, C. Epstein, W. Mobley (2001)
Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusionProceedings of the National Academy of Sciences of the United States of America, 98
A. Insausti, Manuel Megías, D. Crespo, L. Cruz-Orive, M. Dierssen, T. Vallina, R. Insausti, J. Flórez (1998)
Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of down syndromeNeuroscience Letters, 253
Jessica Ash, R. Velazquez, Christy Kelley, B. Powers, S. Ginsberg, E. Mufson, B. Strupp (2014)
Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn miceNeurobiology of Disease, 70
Q. Fan, I. Hanin (2004)
Effects of AF64A on Gene Expression of Choline Acetyltransferase (ChAT) in the Septo-Hippocampal Pathway and Striatum In VivoNeurochemical Research, 24
(2004)
Guide to performing relative quantitation of gene expression using real-time quantitative PCR
R. Velazquez, Jessica Ash, B. Powers, Christy Kelley, M. Strawderman, Zoe Luscher, S. Ginsberg, E. Mufson, B. Strupp (2013)
Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndromeNeurobiology of Disease, 58
K. Gardiner, A. Fortna, L. Bechtel, M. Davisson (2003)
Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions.Gene, 318
I. Lott (2012)
Neurological phenotypes for Down syndrome across the life span.Progress in brain research, 197
E. Akeson, J. Lambert, S. Narayanswami, K. Gardiner, L. Bechtel, M. Davisson (2001)
Ts65Dn – localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndromeCytogenetic and Genome Research, 93
J. Miners, J. Palmer, Hannah Tayler, L. Palmer, E. Ashby, P. Kehoe, S. Love, Robert Marr, Rosalind Franklin, Anthony Turner (2014)
Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymesFrontiers in Aging Neuroscience, 6
L. Bierer, V. Haroutunian, S. Gabriel, P. Knott, Lorna Carlin, D. Purohit, D. Perl, J. Schmeidler, P. Kanof, K. Davis (1995)
Neurochemical Correlates of Dementia Severity in Alzheimer's Disease: Relative Importance of the Cholinergic DeficitsJournal of Neurochemistry, 64
T. Deller, Carlos Orth, D. Turco, A. Vlachos, G. Burbach, A. Drakew, S. Chabanis, M. Korte, H. Schwegler, C. Haas, M. Frotscher (2007)
A role for synaptopodin and the spine apparatus in hippocampal synaptic plasticity.Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft, 189 1
Kelly Wong, H. Lodish (2006)
A Revised Model for AMP-activated Protein Kinase StructureJournal of Biological Chemistry, 281
P. Hooper, H. Durham, Tony Ratliff, Paul Hooper, T. Crul, L. Vígh (2016)
The central role of heat shock factor 1 in synaptic fidelity and memory consolidationCell Stress and Chaperones, 21
R. Bergholdt, S. Eising, Jørn Nerup, F. Pociot (2006)
Increased prevalence of Down’s syndrome in individuals with type 1 diabetes in Denmark: a nationwide population-based studyDiabetologia, 49
Javier Pacheco-Quinto, E. Eckman (2013)
Endothelin-converting Enzymes Degrade Intracellular β-Amyloid Produced within the Endosomal/Lysosomal Pathway and Autophagosomes*The Journal of Biological Chemistry, 288
Q. Shan, G. Chan, D. Storm (2008)
Type 1 Adenylyl Cyclase Is Essential for Maintenance of Remote Contextual Fear MemoryThe Journal of Neuroscience, 28
B. Wang, Y. Liu, L. Huang, J. Chen, JJ Li, R. Wang, E. Kim, Y. Chen, C. Justicia, K. Sakata, H. Chen, A. Planas, RS Ostrom, W. Li, G. Yang, M. McDonald, R. Chen, D. Heck, F. Liao (2016)
A CNS-permeable Hsp90 inhibitor rescues synaptic dysfunction and memory loss in APP-overexpressing Alzheimer’s mouse model via an HSF1-mediated mechanismMolecular psychiatry, 22
M. Davisson, C. Schmidt, R. Reeves, N. Irving, E. Akeson, B. Harris, R. Bronson (1993)
Segmental trisomy as a mouse model for Down syndrome.Progress in clinical and biological research, 384
Henry Teng, K. Teng, Ramee Lee, S. Wright, Seema Tevar, Ramiro Almeida, P. Kermani, Risa Torkin, Zhe-yu Chen, F. Lee, R. Kraemer, A. Nykjaer, B. Hempstead (2005)
ProBDNF Induces Neuronal Apoptosis via Activation of a Receptor Complex of p75NTR and SortilinThe Journal of Neuroscience, 25
R. Wiley, T. Oeltmann, D. Lappi (1991)
Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptorBrain Research, 562
Seungjin Ryu, F. Teles, G. Minopoli, T. Russo, M. Rosenfeld, Y. Suh (2015)
An epigenomic role of Fe65 in the cellular response to DNA damage.Mutation research, 776
A. Salehi, J. Delcroix, P. Belichenko, Ke Zhan, Chengbiao Wu, J. Valletta, Ryoko Takimoto‐Kimura, A. Kleschevnikov, K. Sambamurti, Peter Chung, W. Xia, A. Villar, W. Campbell, L. Kulnane, R. Nixon, B. Lamb, C. Epstein, G. Stokin, L. Goldstein, W. Mobley (2006)
Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron DegenerationNeuron, 51
A. Mckee, K. Kosik, M. Kennedy, N. Kowall (1990)
Hippocampal Neurons Predisposed to Neurofibrillary Tangle Formation Are Enriched in Type II Calcium/Calmodulin-Dependent Protein KinaseJournal of Neuropathology and Experimental Neurology, 49
Randal Ross, S. Hunter, M. Hoffman, Lizbeth McCarthy, Betsey Chambers, Amanda Law, S. Leonard, Gary Zerbe, R. Freedman (2016)
Perinatal Phosphatidylcholine Supplementation and Early Childhood Behavior Problems: Evidence for CHRNA7 Moderation.The American journal of psychiatry, 173 5
Christy Kelley, Jessica Ash, B. Powers, R. Velazquez, M. Alldred, M. Ikonomovic, S. Ginsberg, B. Strupp, E. Mufson (2015)
Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome.Current Alzheimer research, 13 1
O. Scremin, M. Roch, K. Norman, S. Djazayeri, Y.‐Y. Liu (2015)
Brain acetylcholine and choline concentrations and dynamics in a murine model of the Fragile X syndrome: Age, sex and region-specific changesNeuroscience, 301
S. Zeisel, M. Niculescu (2006)
Perinatal choline influences brain structure and function.Nutrition reviews, 64 4
T. Slepak, Lindsey Salay, V. Lemmon, J. Bixby (2012)
Dyrk kinases regulate phosphorylation of doublecortin, cytoskeletal organization, and neuronal morphologyCytoskeleton, 69
R. Agrawal, E. Tyagi, L. Vergnes, K. Reue, F. Gomez-Pinilla (2014)
Coupling energy homeostasis with a mechanism to support plasticity in brain trauma.Biochimica et biophysica acta, 1842 4
Minji Kim, J. Suh, D. Romano, Mimy Truong, K. Mullin, B. Hooli, David Norton, G. Tesco, K. Elliott, Steven Wagner, R. Moir, K. Becker, R. Tanzi (2009)
Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity.Human molecular genetics, 18 20
P. Belichenko, E. Masliah, A. Kleschevnikov, A. Villar, C. Epstein, A. Salehi, W. Mobley (2004)
Synaptic structural abnormalities in the Ts65Dn mouse model of down syndromeJournal of Comparative Neurology, 480
A. Granholm, L. Sanders, Hyemyung Seo, Ling Lin, Kerstin Ford, O. Isacson (2003)
Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndromeHippocampus, 13
Xiumei Guo, Jason Williams, T. Schug, Xiaoling Li (2010)
DYRK1A and DYRK3 Promote Cell Survival through Phosphorylation and Activation of SIRT1*The Journal of Biological Chemistry, 285
Nadia Belichenko, P. Belichenko, A. Kleschevnikov, A. Salehi, R. Reeves, W. Mobley (2009)
The “Down Syndrome Critical Region” Is Sufficient in the Mouse Model to Confer Behavioral, Neurophysiological, and Synaptic Phenotypes Characteristic of Down SyndromeThe Journal of Neuroscience, 29
A. Cataldo, C. Peterhoff, J. Troncoso, T. Gómez-Isla, B. Hyman, R. Nixon (2000)
Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.The American journal of pathology, 157 1
W. Chow, Hei Cheung, Wen Li, K. Lau (2015)
FE65: Roles beyond amyloid precursor protein processingCellular and Molecular Biology Letters, 20
A. Risco, C. Fresno, Agnes Mambol, Dayanira Alsina-Beauchamp, Kirsty Mackenzie, Huei-Ting Yang, D. Barber, Carmen Morcelle, J. Arthur, S. Ley, Carlos Ardavín, A. Cuenda (2012)
p38γ and p38δ kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activationProceedings of the National Academy of Sciences, 109
Ryo Kimura, K. Kamino, M. Yamamoto, Aidaralieva Nuripa, Tomoyuki Kida, H. Kazui, R. Hashimoto, Toshihisa Tanaka, T. Kudo, H. Yamagata, Y. Tabara, T. Miki, H. Akatsu, K. Kosaka, E. Funakoshi, Kouhei Nishitomi, G. Sakaguchi, Akira Kato, H. Hattori, T. Uema, M. Takeda (2007)
The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.Human molecular genetics, 16 1
A. Kleschevnikov, P. Belichenko, M. Faizi, L. Jacobs, K. Htun, M. Shamloo, W. Mobley (2012)
Deficits in Cognition and Synaptic Plasticity in a Mouse Model of Down Syndrome Ameliorated by GABAB Receptor AntagonistsThe Journal of Neuroscience, 32
Hyemyung Seo, O. Isacson (2005)
Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model miceExperimental Neurology, 193
Helen Lockstone, L. Harris, J. Swatton, M. Wayland, Anthony Holland, S. Bahn (2007)
Gene expression profiling in the adult Down syndrome brain.Genomics, 90 6
Yue-Ju Wang, Gui-Hai Chen, Xiang-You Hu, Ya-Ping Lu, Jiang-Ning Zhou, Rong-Yu Liu (2005)
The expression of calcium/calmodulin-dependent protein kinase II-α in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathologyBrain Research, 1031
D. Holtzman, D. Santucci, J. Kilbridge, Jane Chua-Couzens, D. Fontana, S. Daniels, Randolph Johnson, Karen Chen, Yuling Sun, E. Carlson, E. Alleva, C. Epstein, W. Mobley (1996)
Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.Proceedings of the National Academy of Sciences of the United States of America, 93 23
R. Escorihuela, A. Fernández-Teruel, I. Vallina, C. Baamonde, M. Lumbreras, M. Dierssen, A. Tobeña, J. Flórez (1995)
A behavioral assessment of Ts65Dn mice: a putative Down syndrome modelNeuroscience Letters, 199
Y. Benjamini, Y. Hochberg (1995)
Controlling the false discovery rate: a practical and powerful approach to multiple testingJournal of the royal statistical society series b-methodological, 57
Xiaolu Sturgeon, K. Gardiner (2011)
Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regionsMammalian Genome, 22
X. Yao, Jiao Ss, K. Saadipour, Fan Zeng, Wang Qh, Chi Zhu, Lin-Lin Shen, Zeng Gh, Liang Cr, J. Wang, Yu-Hui Liu, Hou Hy, Xiang Xu, Su Yp, Xiaotang Fan, Xiao Hl, L. Lue, Zeng Yq, B. Giunta, Zhong Jh, Douglas Walker, Hua-Dong Zhou, Jun Tan, Xin-Fu Zhou, Xin-Fu Zhou, Yan-Jiang Wang (2015)
p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's diseaseMolecular Psychiatry, 20
M. Alldred, K. Duff, S. Ginsberg (2012)
Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunctionNeurobiology of Disease, 45
M. Tress (2003)
Generalized, Linear, and Mixed ModelsTechnometrics, 45
S. Ginsberg (2010)
Alterations in discrete glutamate receptor subunits in adult mouse dentate gyrus granule cells following perforant path transectionAnalytical and Bioanalytical Chemistry, 397
A. Granholm, L. Sanders, L. Crnic (2000)
Loss of Cholinergic Phenotype in Basal Forebrain Coincides with Cognitive Decline in a Mouse Model of Down's SyndromeExperimental Neurology, 161
D. Rye, B. Wainer, M. Mesulam, E. Mufson, C. Saper (1984)
Cortical projections arising from the basal forebrain: A study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferaseNeuroscience, 13
B. Strupp, B. Powers, R. Velazquez, Jessica Ash, Christy Kelley, M. Alldred, M. Strawderman, M. Caudill, E. Mufson, S. Ginsberg (2015)
Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.Current Alzheimer research, 13 1
M. Alldred, Shaoli Che, S. Ginsberg (2009)
Terminal continuation (TC) RNA amplification without second strand synthesisJournal of Neuroscience Methods, 177
S. Ginsberg (2005)
Glutamatergic neurotransmission expression profiling in the mouse hippocampus after perforant-path transection.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 13 12
R. Siarey, E. Carlson, C. Epstein, A. Balbo, S. Rapoport, Z. Galdzicki (1999)
Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndromeNeuropharmacology, 38
Laura Mcintire, D. Berman, Jennifer Myaeng, Agnieszka Staniszewski, O. Arancio, G. Paolo, Tae‐Wan Kim (2012)
Reduction of Synaptojanin 1 Ameliorates Synaptic and Behavioral Impairments in a Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 32
Ying Jiang, Kerry Mullaney, C. Peterhoff, Shaoli Che, S. Schmidt, Anne Boyer-Boiteau, S. Ginsberg, A. Cataldo, P. Mathews, R. Nixon (2009)
Alzheimer’s-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibitionProceedings of the National Academy of Sciences, 107
E. Mufson, S. Counts, S. Perez, S. Ginsberg (2008)
Cholinergic system during the progression of Alzheimer’s disease: therapeutic implicationsExpert Review of Neurotherapeutics, 8
A. Cataldo, S. Petanceska, C. Peterhoff, Nicole Terio, C. Epstein, A. Villar, E. Carlson, M. Staufenbiel, R. Nixon (2003)
App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down SyndromeThe Journal of Neuroscience, 23
Christy Kelley, B. Powers, R. Velazquez, Jessica Ash, S. Ginsberg, B. Strupp, E. Mufson (2014)
Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young‐adult Ts65Dn and disomic miceJournal of Comparative Neurology, 522
C. Bearer, K. Wellmann, N. Tang, Min He, S. Mooney (2015)
Choline Ameliorates Deficits in Balance Caused by Acute Neonatal Ethanol ExposureThe Cerebellum, 14
E. Blalock, Heather Buechel, J. Popović, J. Geddes, P. Landfield (2011)
Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's diseaseJournal of Chemical Neuroanatomy, 42
Tiffany Mellott, Olivia Huleatt, Bethany Shade, S. Pender, Yi Liu, B. Slack, J. Blusztajn (2017)
Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model MicePLoS ONE, 12
M. Schafer, Igor Dolgalev, M. Alldred, A. Heguy, S. Ginsberg (2015)
Calorie Restriction Suppresses Age-Dependent Hippocampal Transcriptional SignaturesPLoS ONE, 10
K. Wisniewski, A. Dalton, D. McLachlan, G. Wen, H. Wisniewski (2011)
Alzheimer's disease in Down's syndrome: Clinicopathologic studiesNeurology, 77
S. Ginsberg (2008)
Transcriptional profiling of small samples in the central nervous system.Methods in molecular biology, 439
D. Mann, P. Yates, B. Marcyniuk, C. Ravindra (1986)
THE TOPOGRAPHY OF PLAQUES AND TANGLES IN DOWN'S SYNDROME PATIENTS OF DIFFERENT AGESNeuropathology and Applied Neurobiology, 12
A. Esbensen (2010)
Health conditions associated with aging and end of life of adults with Down syndrome.International review of research in mental retardation, 39 C
B. Powers, R. Velazquez, Christy Kelley, Jessica Ash, M. Strawderman, M. Alldred, S. Ginsberg, E. Mufson, B. Strupp (2016)
Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndromeBrain Structure and Function, 221
S. Ginsberg (2005)
RNA amplification strategies for small sample populations.Methods, 37 3
Gurjinder Kaur, Ajay Sharma, Wenjin Xu, S. Gerum, M. Alldred, Shivakumar Subbanna, B. Basavarajappa, M. Pawlik, M. Ohno, S. Ginsberg, D. Wilson, D. Guilfoyle, E. Levy (2014)
Glutamatergic Transmission Aberration: A Major Cause of Behavioral Deficits in a Murine Model of Down's SyndromeThe Journal of Neuroscience, 34
L. Gatta, A. Albertini, R. Ravid, D. Finazzi (2002)
Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus.Neuroreport, 13 16
Da Wang, D. Jong, A. Rühling, V. Lesch, K. Shimizu, S. Wulff, A. Heuer, F. Glorius, H. Franke (2016)
Imidazolium-Based Lipid Analogues and Their Interaction with Phosphatidylcholine Membranes.Langmuir : the ACS journal of surfaces and colloids, 32 48
Sarah Martin, A. Dowling, Joann Lianekhammy, I. Lott, I. Lott, E. Doran, E. Doran, M. Murphy, T. Beckett, F. Schmitt, E. Head (2014)
Synaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer's disease.Journal of Alzheimer's disease : JAD, 42 3
Lynn Hyde, L. Crnic (2001)
Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease.Behavioral neuroscience, 115 6
M. Mehedint, M. Niculescu, C. Craciunescu, S. Zeisel (2010)
Choline deficiency alters global histone methylation and epigenetic marking at the Rel site of the calbindin 1 geneThe FASEB Journal, 24
Susana García-Cerro, P. Martínez, V. Vidal, A. Corrales, J. Flórez, R. Vidal, N. Rueda, M. Arbonés, C. Martínez-Cué (2014)
Overexpression of Dyrk1A Is Implicated in Several Cognitive, Electrophysiological and Neuromorphological Alterations Found in a Mouse Model of Down SyndromePLoS ONE, 9
B. Powers, Christy Kelley, R. Velazquez, Jessica Ash, M. Strawderman, M. Alldred, S. Ginsberg, E. Mufson, B. Strupp (2017)
Maternal choline supplementation in a mouse model of Down syndrome: Effects on attention and nucleus basalis/substantia innominata neuron morphology in adult offspringNeuroscience, 340
J. Leverenz, M. Raskind (1998)
Early Amyloid Deposition in the Medial Temporal Lobe of Young Down Syndrome Patients: A Regional Quantitative AnalysisExperimental Neurology, 150
T. Sendera, S.Y. Ma, S. Jaffar, P. Kozlowski, J. Kordower, Y. Mawal, H. Saragovi, E. Mufson (2000)
Reduction in TrkA‐Immunoreactive Neurons Is Not Associated with an Overexpression of Galaninergic Fibers Within the Nucleus Basalis in Down's SyndromeJournal of Neurochemistry, 74
N. Rai, Rahul Kumar, G. Desai, G. Venugopalan, S. Shekhar, P. Chatterjee, M. Tripathi, A. Upadhyay, S. Dwivedi, A. Dey, S. Dey (2016)
Relative Alterations in Blood-Based Levels of Sestrin in Alzheimer's Disease and Mild Cognitive Impairment Patients.Journal of Alzheimer's disease : JAD, 54 3
Christopher Hunter, H. Bimonte, A. Granholm (2003)
Behavioral comparison of 4 and 6 month-old Ts65Dn mice: Age-related impairments in working and reference memoryBehavioural Brain Research, 138
Annalisa Cavallini, S. Brewerton, Amanda Bell, Samantha Sargent, Sarah Glover, Clare Hardy, R. Moore, J. Calley, Devaki Ramachandran, M. Poidinger, E. Karran, P. Davies, M. Hutton, P. Szekeres, S. Bose (2013)
An Unbiased Approach to Identifying Tau Kinases That Phosphorylate Tau at Sites Associated with Alzheimer DiseaseThe Journal of Biological Chemistry, 288
Kaichuan Zhu, X. Xiang, S. Filser, P. Marinković, M. Dorostkar, Sophie Crux, U. Neumann, D. Shimshek, G. Rammes, C. Haass, S. Lichtenthaler, J. Gunnersen, J. Herms (2016)
Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6Biological Psychiatry, 83
N. Rueda, M. Llorens-Martín, J. Flórez, E. Valdizán, P. Banerjee, J. Trejo, C. Martínez-Cué (2010)
Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome.Journal of Alzheimer's disease : JAD, 21 1
S. Ginsberg, Shaoli Che, J. Wuu, S. Counts, E. Mufson (2006)
Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's diseaseJournal of Neurochemistry, 97
F. Lai, Roger Williams (1989)
A prospective study of Alzheimer disease in Down syndrome.Archives of neurology, 46 8
M. Alldred, Sang Lee, E. Petkova, S. Ginsberg (2015)
Expression profile analysis of vulnerable CA1 pyramidal neurons in young–Middle‐Aged Ts65Dn miceJournal of Comparative Neurology, 523
A. Conti, C. Young, J. Olney, L. Muglia (2009)
Adenylyl cyclases types 1 and 8 promote pro-survival pathways after ethanol exposure in the neonatal brainNeurobiology of Disease, 33
S. Hartley, B. Handen, D. Devenny, Regina Hardison, Iulia Mihaila, J. Price, A. Cohen, W. Klunk, Marsha Mailick, Sterling Johnson, B. Christian (2014)
Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome.Brain : a journal of neurology, 137 Pt 9
K. Stevens, C. Adams, J. Yonchek, C. Hickel, Jeffrey Danielson, M. Kisley (2008)
Permanent improvement in deficient sensory inhibition in DBA/2 mice with increased perinatal cholinePsychopharmacology, 198
A. Kleschevnikov, P. Belichenko, A. Villar, C. Epstein, R. Malenka, W. Mobley (2004)
Hippocampal Long-Term Potentiation Suppressed by Increased Inhibition in the Ts65Dn Mouse, a Genetic Model of Down SyndromeThe Journal of Neuroscience, 24
Q. Cheng, J. Yakel (2015)
Activation of α7 nicotinic acetylcholine receptors increases intracellular cAMP levels via activation of AC1 in hippocampal neuronsNeuropharmacology, 95
Susana García-Cerro, N. Rueda, V. Vidal, Sara Lantigua, C. Martínez-Cué (2017)
Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypesNeurobiology of Disease, 106
Jolanta Lundgren, Saheeb Ahmed, Sophia Schedin‐Weiss, G. Gouras, B. Winblad, L. Tjernberg, Susanne Frykman (2015)
ADAM10 and BACE1 are localized to synaptic vesiclesJournal of Neurochemistry, 135
R. Haque, A. Nazir (2014)
Insulin-degrading enzyme: a link between Alzheimer's and type 2 diabetes mellitus.CNS & neurological disorders drug targets, 13 2
R. Chapman, L. Hesketh (2000)
Behavioral phenotype of individuals with Down syndrome.Mental retardation and developmental disabilities research reviews, 6 2
Emily Petrus, Hey-Kyoung Lee (2014)
BACE1 Is Necessary for Experience-Dependent Homeostatic Synaptic Plasticity in Visual CortexNeural Plasticity, 2014
Eliane Ebnoether, A. Ramseier, Maurizio Cortada, D. Bodmer, Soledad Levano-Huaman (2017)
Sesn2 gene ablation enhances susceptibility to gentamicin-induced hair cell death via modulation of AMPK/mTOR signalingCell Death Discovery, 3
E. Mufson, B. He, M. Nadeem, S. Perez, S. Counts, S. Leurgans, J. Fritz, J. Lah, S. Ginsberg, J. Wuu, S. Scheff (2012)
Hippocampal ProNGF Signaling Pathways and &bgr;-Amyloid Levels in Mild Cognitive Impairment and Alzheimer DiseaseJournal of Neuropathology & Experimental Neurology, 71
(2018)
CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation
M. Caudill, B. Strupp, Laura Muscalu, Julie Nevins, R. Canfield (2017)
Maternal choline supplementation during the third trimester of pregnancy improves infant information processing speed: a randomized, double‐blind, controlled feeding studyThe FASEB Journal, 32
Kuo-Hui Su, C. Dai (2016)
Metabolic control of the proteotoxic stress response: implications in diabetes mellitus and neurodegenerative disordersCellular and Molecular Life Sciences, 73
Ying Jiang, Andrew Rigoglioso, C. Peterhoff, M. Pawlik, Yutaka Sato, C. Bleiwas, Philip Stavrides, J. Smiley, S. Ginsberg, P. Mathews, E. Levy, R. Nixon (2016)
Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTFNeurobiology of Aging, 39
Li Lin, Chadwick Hales, K. Garber, P. Jin (2014)
Fat mass and obesity-associated (FTO) protein interacts with CaMKII and modulates the activity of CREB signaling pathway.Human molecular genetics, 23 12
M. Rachidi, C. Lopes (2008)
Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 12 3
A. Anwar, J. Walker, B. Frier (1998)
Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complicationsDiabetic Medicine, 15
P. Kahlem, M. Sultan, R. Herwig, M. Steinfath, Daniela Balzereit, Barbara Eppens, Nidhi Saran, M. Pletcher, S. South, G. Stetten, H. Lehrach, R. Reeves, M. Yaspo (2004)
Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome.Genome research, 14 7
S. Ginsberg (2014)
Considerations in the Use of Microarrays for Analysis of the CNS
M. Alldred, Shaoli Che, S. Ginsberg (2008)
Terminal Continuation (TC) RNA Amplification Enables Expression Profiling Using Minute RNA Input Obtained from Mouse BrainInternational Journal of Molecular Sciences, 9
J. Fombonne, S. Rabizadeh, Surita Banwait, P. Mehlen, D. Bredesen (2009)
Selective vulnerability in Alzheimer's disease: Amyloid precursor protein and p75NTR interactionAnnals of Neurology, 65
J. Cossec, J. Lavaur, D. Berman, I. Rivals, A. Hoischen, S. Stora, C. Ripoll, C. Mircher, Yann Grattau, Jean-Christophe Olivomarin, Fabrice Chaumont, M. Lecourtois, S. Antonarakis, J. Veltman, J. Delabar, C. Duyckaerts, G. Paolo, M. Potier (2012)
Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes.Human molecular genetics, 21 14
G. Sumara, Ivan Formentini, S. Collins, I. Sumara, Renata Windak, B. Bodenmiller, R. Ramracheya, D. Caille, Huiping Jiang, K. Platt, P. Meda, R. Aebersold, P. Rorsman, R. Ricci (2009)
Regulation of PKD by the MAPK p38δ in Insulin Secretion and Glucose HomeostasisCell, 136
Bonnie Ward, S. Agarwal, K. Wang, J. Berger-Sweeney, N. Kolodny (2008)
Longitudinal brain MRI study in a mouse model of Rett Syndrome and the effects of cholineNeurobiology of Disease, 31
Bonnie Ward, N. Kolodny, N. Nag, J. Berger-Sweeney (2009)
Neurochemical changes in a mouse model of Rett syndrome: changes over time and in response to perinatal choline nutritional supplementationJournal of Neurochemistry, 108
E. Eckman, Mona Watson, L. Marlow, K. Sambamurti, C. Eckman (2003)
Alzheimer's Disease β-Amyloid Peptide Is Increased in Mice Deficient in Endothelin-converting Enzyme*The Journal of Biological Chemistry, 278
W. Qiu, D. Walsh, Z. Ye, K. Vekrellis, Jimin Zhang, M. Podlisny, M. Rosner, A. Safavi, L. Hersh, D. Selkoe (1998)
Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation*The Journal of Biological Chemistry, 273
P. Detopoulou, D. Panagiotakos, Smaragdi Antonopoulou, C. Pitsavos, C. Stefanadis (2008)
Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: the ATTICA study.The American journal of clinical nutrition, 87 2
A. Duchon, M. Raveau, C. Chevalier, Valérie Nalesso, A. Sharp, Y. Hérault (2011)
Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndromeMammalian Genome, 22
Shaoli Che, S. Ginsberg (2004)
Amplification of RNA transcripts using terminal continuationLaboratory Investigation, 84
C. Feijóo, D. Campbell, R. Jakes, M. Goedert, A. Cuenda (2005)
Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38δ at Thr50 promotes microtubule assemblyJournal of Cell Science, 118
L. Driscoll, J. Carroll, Jisook Moon, L. Crnic, D. Levitsky, B. Strupp (2004)
Impaired sustained attention and error-induced stereotypy in the aged Ts65Dn mouse: a mouse model of Down syndrome and Alzheimer's disease.Behavioral neuroscience, 118 6
Although there are changes in gene expression and alterations in neuronal density and afferent inputs in the forebrain of trisomic mouse models of Down syndrome (DS) and Alzheimer's disease (AD), there is a lack of systematic assessments of gene expression and encoded proteins within individual vulnerable cell populations, precluding translational investigations at the molecular and cellular level. Further, no effective treatment exists to combat intellectual disability and basal forebrain cholinergic neurodegeneration seen in DS. To further our understanding of gene expression changes before and following cholinergic degeneration in a well‐established mouse model of DS/AD, the Ts65Dn mouse, we assessed RNA expression levels from CA1 pyramidal neurons at two adult ages (∼6 months of age and ∼11 months of age) in both Ts65Dn and their normal disomic (2N) littermates. We further examined a therapeutic intervention, maternal choline supplementation (MCS), which has been previously shown to lessen dysfunction in spatial cognition and attention, and have protective effects on the survival of basal forebrain cholinergic neurons in the Ts65Dn mouse model. Results indicate that MCS normalized expression of several genes in key gene ontology categories, including synaptic plasticity, calcium signaling, and AD‐associated neurodegeneration related to amyloid‐beta peptide (Aβ) clearance. Specifically, normalized expression levels were found for endothelin converting enzyme‐2 (Ece2), insulin degrading enzyme (Ide), Dyrk1a, and calcium/calmodulin‐dependent protein kinase II (Camk2a), among other relevant genes. Single population expression profiling of vulnerable CA1 pyramidal neurons indicates that MCS is a viable therapeutic for long‐term reprogramming of key transcripts involved in neuronal signaling that are dysregulated in the trisomic mouse brain which have translational potential for DS and AD.
Hippocampus – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.